Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats

International Journal of Molecular Medicine

Volumn 33, Issue 2, 2014, Pages 263-270

  Wang, Hongwu ^a   Qiu, Xiaoyan ^a   Ni, Ping ^c   Qiu, Xuerong ^a   Lin, Xiaobo ^a   Wu, Weizhao ^a   Xie, Lichun ^a   Lin, Limin ^a   Min, Juan ^d   Lai, Xiulan ^a   Chen, Yunbin ^a,b   Ho, Guyu ^a   Ma, Lian ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Guangdong Women and Children's Hospital   (China)

^c CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d Clinical Medical Research Center   (China)

Author keywords

Hyperglycemic; Immunological characteristics; Mesenchymal stem cells; Transplantation; Umbilical cord

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; COLONY FORMATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION; HYPERGLYCEMIA; IMMUNOREGULATION; IN VIVO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYPERGLYCEMIA; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PHENOTYPE; RATS; UMBILICAL CORD;

EID: 84893798593     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1572     Document Type: Article

References (31)

1. Atkinson MA and Eisenbarth GS: Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 358: 221-229, 2001.
2. Noguchi H: Pancreatic islet transplantation. World J Gastrointest Surg 1: 16-20, 2009.
3. Matsumoto S: Islet cell transplantation for Type 1 diabetes. J Diabetes 2: 16-22, 2010.
4. Shapiro AM, Lakey JR, Ryan EA, et al: Islet transplantation in seven patients with type 1 diabetes mellitus using a gluco-corticoid-free immunostippressive regimen. N Engl J Med 343: 230-238, 2000.
5. Wang HW, Lin LM, He HY, et al: Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chin Med J 124: 1534-1539, 2011.
6. Jiang J, Au M, Lu K, et al: Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25: 1940-1953, 2007.
7. Karnieli O, Izhar-Prato Y, Bulvik S, et al: Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25: 2837-2844, 2007.
8. Mueller SM and Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82: 583-590, 2001.
9. Stenderup K, Justesen J, Clausen C and Kassem M: Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926, 2003.
10. Xie QP, Huang H, Xu B, et al: Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation 7: 483-91, 2009.
11. Shi Y. Generation of functional insulin-producing cells from human embryonic stem cells in vitro. Methods Mol Biol 636: 79-85, 2010.
12. Le Blanc K, Tammik L, Sundberg B, et al: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20, 2003.
13. Krampera M, Glennie S, Dyson J, et al: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729, 2003.
14. Meisel R, Zibert A, Laryea M, et al: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621, 2004.
15. Alhadlaq A and Mao JJ: Mesenchymal stem cells: Isolation and therapeutics. Stem Cells Dev 13: 436-438, 2004.
16. Le Blanc K and Pittenger M: Mesenchymal stem cells: Progress toward promise. Cytotherapy 7: 36-45, 2005.
17. Beyer Nardi N and da Silva Meirelles L: Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174: 249-282, 2006.
18. Wang HS, Hung SC, Peng ST, et al: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337, 2004.
19. Ma L, Feng XY, Cui BL, et al: Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin Med J 118: 1987-1993, 2005
20. Qian Q, Qian H, Zhang X, et al: 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev 21: 67-75, 2012.
21. He D, Wang J, Gao Y and Zhang Y: Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. Int J Mol Med 28: 1019-1024, 2011.
22. Huang P, Lin LM, Wu XY, et al: Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into germ-like cells in vitro. J Cell Biochem 109: 747-754, 2010.
23. Ghio M, Contini P. Negrini S, et al: Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Eur J Immunol 39: 3459-3468, 2009.
24. Stumpf AN, van der Meijden ED, van Bergen CA, et al: Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 114: 3684-3692, 2009.
25. Antin JH: Clinical practice. Long-term care after hematopoietic-cell transplantation in adults. N Engl J Med 347: 36-42, 2002.
26. Leitner J, Kuschei W, Grabmeier-Pfistershammer K, et al: T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells. J Immunol Methods 362: 131-141, 2010.
27. Shi M, Liu ZW, Wang FS: Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164: 1-8, 2011.
28. Sioud M: New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins. Scand J Immunol 73: 79-84, 2011.
29. Yagi H, Soto-Gutierrez A, Parekkadan B, et al: Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19: 667-679, 2010.
30. Aggarwal S and Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822, 2005.
31. Yano S, Kuroda S, Shichinohe H, et al: Bone marrow stromal cell transplantation preserves gamma aminobutyric acid receptor function in the injured spinal cord. J Neurotrauma 23: 1682-1692, 2006.